Regeneron Pharmaceuticals (REGN) Current Deferred Revenue (2009 - 2026)
Regeneron Pharmaceuticals (REGN) reported Current Deferred Revenue of $684.8 million for Q2 2026, up 42.1% from $481.9 million a year earlier and up 7.6% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Current Deferred Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals posted Current Deferred Revenue of $553 million, down 11.9% from FY2024.
- Current Deferred Revenue has a five-year compound annual growth rate of -0.9% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $627.7 million in FY2024 (+36.8%), $458.9 million in FY2023 (-4.0%), $477.9 million in FY2022 (+8.1%) and $442 million in FY2021 (-23.5%).
- The Q2 2026 figure ranks as the highest quarterly Current Deferred Revenue in data going back to Q4 2009.
- Year over year, Current Deferred Revenue gained in five of the last eight quarters, with growth averaging 13.6%.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2024 (growth of 53.8%); the low point was Q2 2023 (a decline of 32.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $636.2 million (Q1 2026), $553 million (Q4 2025) and $545.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn |
| 10 | Regeneron Pharmaceuticals | 91.70 Bn | 57.05 Bn | 4.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 749.80 Mn |
| Jun 30, 2026 | 684.80 Mn |
| Mar 31, 2026 | 636.20 Mn |
| Dec 31, 2025 | 553.00 Mn |
| Sep 30, 2025 | 545.60 Mn |
| Jun 30, 2025 | 481.90 Mn |
| Mar 31, 2025 | 619.30 Mn |
| Dec 31, 2024 | 627.70 Mn |
| Sep 30, 2024 | 627.20 Mn |
| Jun 30, 2024 | 586.00 Mn |
| Mar 31, 2024 | 516.70 Mn |
| Dec 31, 2023 | 458.90 Mn |
| Sep 30, 2023 | 417.30 Mn |
| Jun 30, 2023 | 381.10 Mn |
| Mar 31, 2023 | 426.30 Mn |
| Dec 31, 2022 | 477.90 Mn |
| Sep 30, 2022 | 547.20 Mn |
| Jun 30, 2022 | 566.30 Mn |
| Mar 31, 2022 | 491.30 Mn |
| Dec 31, 2021 | 442.00 Mn |
API Access
Regeneron Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();